Raccosta, Laura
Marinozzi, Maura http://orcid.org/0000-0001-5994-9390
Costantini, Susan
Maggioni, Daniela
Ferreira, Lorena Maria
Corna, Gianfranca
Zordan, Paola
Sorice, Angela
Farinello, Diego
Bianchessi, Silvia
Riba, Michela
Lazarevic, Dejan http://orcid.org/0000-0003-4527-290X
Provero, Paolo
Mack, Matthias http://orcid.org/0000-0002-3157-7262
Bondanza, Attilio
Nalvarte, Ivan http://orcid.org/0000-0001-6828-2583
Gustafsson, J-A
Ranzani, Valeria
De Sanctis, Francesco
Ugel, Stefano http://orcid.org/0000-0002-6639-7608
Baron, Silvère
Lobaccaro, Jean-Marc A.
Pontini, Lorenzo
Pacciarini, Manuela
Traversari, Catia
Pagani, Massimiliano
Bronte, Vincenzo http://orcid.org/0000-0002-3741-5141
Sitia, Giovanni http://orcid.org/0000-0003-1024-9128
Antonson, Per
Brendolan, Andrea
Budillon, Alfredo http://orcid.org/0000-0002-6330-6053
Russo, Vincenzo http://orcid.org/0000-0003-1592-5041
Funding for this research was provided by:
Fondazione Umberto Veronesi
Associazione Italiana per la Ricerca sul Cancro (IG 19016, IG 15452, IG 26305, IG 22737)
Article History
Received: 1 December 2022
Revised: 23 January 2023
Accepted: 25 January 2023
First Online: 15 February 2023
Competing interests
: Attilio Bondanza is an employee of AstraZeneca. No other potential conflicts of interest were disclosed. There are patent applications pending related to this work.